Dr. Christopher S. Platta
Claim this profileAspirus Regional Cancer Center
Studies Prostate Cancer
Studies Lung Cancer
12 reported clinical trials
38 drugs studied
Area of expertise
1Prostate Cancer
Stage IV
synaptophysin positive
chromogranin positive
2Lung Cancer
Stage IV
Affiliated Hospitals
Clinical Trials Christopher S. Platta is currently running
7-Gene Biosignature
for Ductal Carcinoma
This is a prospective, non-interventional (observational) cohort study conducted within the medical network of the participating investigators and institutions. Patients meeting the eligibility criteria (see below) will be eligible for participation and the investigators will obtain written informed consent. A central Institutional Review Board (IRB), WCG IRB, will approve the protocol and each participating institution.
Recruiting1 award N/A7 criteria
Chemotherapy + Radiotherapy
for Esophageal and Gastric Cancer
This phase III trial studies how well the addition of radiotherapy to the usual treatment (chemotherapy) works compared to the usual treatment alone in treating patients with esophageal and gastric cancer that has spread to a limited number of other places in the body (oligometastatic disease). Radiotherapy uses high energy x-rays, gamma rays, or protons to kill tumor cells and shrink tumors. Drugs used in usual chemotherapy, such as leucovorin, 5-fluorouracil, oxaliplatin, and capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Adding radiotherapy to the usual chemotherapy may work better compared to the usual chemotherapy alone in treating patients with esophageal and gastric cancer.
Recruiting2 awards Phase 320 criteria
More about Christopher S. Platta
Clinical Trial Related7 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Christopher S. Platta has experience with
- Docetaxel
- Radiation Therapy
- Flutamide
- Goserelin Acetate
- Nilutamide
- Atezolizumab
Breakdown of trials Christopher S. Platta has run
Prostate Cancer
Lung Cancer
Small Cell Lung Cancer
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Christopher S. Platta specialize in?
Christopher S. Platta focuses on Prostate Cancer and Lung Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are synaptophysin positive.
Is Christopher S. Platta currently recruiting for clinical trials?
Yes, Christopher S. Platta is currently recruiting for 6 clinical trials in Wausau Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Christopher S. Platta has studied deeply?
Yes, Christopher S. Platta has studied treatments such as Docetaxel, Radiation Therapy, Flutamide.
What is the best way to schedule an appointment with Christopher S. Platta?
Apply for one of the trials that Christopher S. Platta is conducting.
What is the office address of Christopher S. Platta?
The office of Christopher S. Platta is located at: Aspirus Regional Cancer Center, Wausau, Wisconsin 54401 United States. This is the address for their practice at the Aspirus Regional Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.